These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4518608)

  • 1. Methylated psychotogens in the urine of psychiatric patients.
    Kanabus P; Krysa G; Matsumoto H; Stencka K
    Act Nerv Super (Praha); 1973 May; 15(2):124. PubMed ID: 4518608
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hallucinogen excretion in untreated psychiatric patients].
    Kanabus P; Krysa G; Matsumoto H
    Psychiatr Pol; 1973; 7(5):517-23. PubMed ID: 4520107
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of drug-free schizophrenics and controls.
    Narasimhachari N; Avalos J; Fujimori M; Himwich HE
    Biol Psychiatry; 1973 Dec; 5(3):311-8. PubMed ID: 4513564
    [No Abstract]   [Full Text] [Related]  

  • 4. Gas chromatographic-mass spectrometric identification of urinary bufotenin and dimethyltryptamine in drug-free chronic schizophrenic patients.
    Narasimhachari N; Baumann P; Pak HS; Carpenter WT; Zocchi AF; Hokanson L; Fujimori M; Himwich HE
    Biol Psychiatry; 1974 Jun; 8(3):293-305. PubMed ID: 4527813
    [No Abstract]   [Full Text] [Related]  

  • 5. [N,N-dimethyltryptamine and bufotenin in the urine of patients with chronic and acute schizophrenic psychoses].
    Rosengarten H; Szemis A; Piotrowski A; Romaszewska K; Matsumoto H; Stencka K; Jus A
    Psychiatr Pol; 1970; 4(5):519-21. PubMed ID: 5483205
    [No Abstract]   [Full Text] [Related]  

  • 6. Gas chromatographic-mass spectrometric identification of N:N-dimethyltryptamine in urine samples from drug-free chronic schizophrenic patients and its quantitation by the technique of single (selective) ion monitoring.
    Narasimhachari N; Himwich HE
    Biochem Biophys Res Commun; 1973 Dec; 55(4):1064-71. PubMed ID: 4520847
    [No Abstract]   [Full Text] [Related]  

  • 7. The excretion of dimethyltryptamine in psychiatric patients.
    Murray RM; Oon MC
    Proc R Soc Med; 1976 Nov; 69(11):831-2. PubMed ID: 1070023
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary amines in chronic schizophrenia.
    Perry TL; Hansen S; MacDougall L
    Nature; 1966 Oct; 212(5058):146-8. PubMed ID: 5339580
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urinary excretion of bufotenin, N,N-dimethyltryptamine and 3,4-dimethoxyphenylethylamine and the clinical picture of mental disorders].
    Matsumoto H; Pietruszewska I
    Psychiatr Pol; 1978; 12(2):189-97. PubMed ID: 275869
    [No Abstract]   [Full Text] [Related]  

  • 10. [Endogenous hallucinogens].
    Kanabus P; Frindt-Zajaczkowska A
    Psychiatr Pol; 1974; 8(2):197-202. PubMed ID: 4830327
    [No Abstract]   [Full Text] [Related]  

  • 11. A biochemical study of early infantile austism.
    Himwich HE; Jenkins RL; Fujimori M; Narasimhachari N; Ebersole M
    J Autism Child Schizophr; 1972; 2(2):114-26. PubMed ID: 5068665
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary excretion of dimethyltryptamine in liver disease.
    Checkley SA; Oon MC; Rodnight R; Murphy MP; Williams RS; Birley JL
    Am J Psychiatry; 1979 Apr; 136(4A):439-41. PubMed ID: 284722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of bufotenin (5-hydroxy-N,N-dimethyltryptamine) in urine of schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Life Sci; 1967 Aug; 6(16):1697-706. PubMed ID: 6057885
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cerebral biochemical disorders and mental diseases. A propos of the "pink spot"].
    Delay J; Boissier JR; Deniker P; Simon P; Ginestet D; Wirz-Justice A
    Encephale; 1969; 58(4):360-76. PubMed ID: 5378191
    [No Abstract]   [Full Text] [Related]  

  • 15. Biological heterogeneity in schizophrenic patients.
    Buchsbaum MS; Davis GC
    Am J Psychiatry; 1979 Dec; 136(12):1618. PubMed ID: 292318
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary studies of schizophrenics and controls.
    Narasimhachari N; Heller B; Spaide J; Haskovec L; Fujimori M; Tabushi K; Himwich HE
    Biol Psychiatry; 1971; 3(1):9-20. PubMed ID: 4398666
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary excretion of n,n-dimethylated tryptamines in chronic schizophrenia. A review of the present status of the hypothesis.
    Huszka L; Zabek DH; Doust JW
    Can Psychiatr Assoc J; 1976 Dec; 21(8):541-6. PubMed ID: 1071579
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of psychotomimetic N,N-dimethylated indoleamines in the urine of four schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Br J Psychiatry; 1970 Oct; 117(539):421-30. PubMed ID: 5312352
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-phenylethylamine in human urine.
    Fischer E; Heller B; Miró AH
    Arzneimittelforschung; 1968 Nov; 18(11):1486. PubMed ID: 5755919
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of potentially hallucinogenic N-dimethylated indoleamines in human urine by HPLC/ESI-MS-MS.
    Forsström T; Tuominen J; Karkkäinen J
    Scand J Clin Lab Invest; 2001; 61(7):547-56. PubMed ID: 11763413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.